139 related articles for article (PubMed ID: 30455958)
1. Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials.
Shimazawa R; Kano Y; Ikeda M
Pharmacol Res Perspect; 2018 Dec; 6(6):e00435. PubMed ID: 30455958
[TBL] [Abstract][Full Text] [Related]
2. Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances.
Gahr M; Connemann BJ; Muche R; Zeiss R; Wolf A
Eur J Clin Pharmacol; 2022 Mar; 78(3):419-434. PubMed ID: 34705065
[TBL] [Abstract][Full Text] [Related]
3. Information for adequate prescribing to older patients : an evaluation of the product information of 53 recently approved medicines.
Beers E; Egberts TC; Leufkens HG; Jansen PA
Drugs Aging; 2013 Apr; 30(4):255-62. PubMed ID: 23420118
[TBL] [Abstract][Full Text] [Related]
4. What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics.
Albassam A; Hughes DA
Eur J Clin Pharmacol; 2021 Feb; 77(2):251-260. PubMed ID: 32989529
[TBL] [Abstract][Full Text] [Related]
5. [Use of summaries of product characteristics (SmPC) among family doctors and pharmacists in the context of the aut-idem regulation: Results of an exploratory cross-sectional survey].
Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():45-53. PubMed ID: 32444219
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.
Weersink RA; Timmermans L; Monster-Simons MH; Mol PGM; Metselaar HJ; Borgsteede SD; Taxis K
Front Pharmacol; 2019; 10():1031. PubMed ID: 31607904
[No Abstract] [Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Information in summaries of product characteristics about use in children is limited and needs standardisation: a systematic analysis in Switzerland.
Tilen R; Berger C; Allemann S; Meyer Zu Schwabedissen H
Arch Dis Child; 2024 Jun; 109(7):586-591. PubMed ID: 38448199
[TBL] [Abstract][Full Text] [Related]
9. Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation.
Arguello B; Salgado TM; Fernandez-Llimos F
Br J Clin Pharmacol; 2015 Mar; 79(3):537-44. PubMed ID: 25224071
[TBL] [Abstract][Full Text] [Related]
10. Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs.
Weisbach L; Schuster AK; Hartmann M; Dürr P; Then MI; Andrikyan W; Fromm MF; Maas R; Farker K
Br J Clin Pharmacol; 2023 Aug; 89(8):2552-2560. PubMed ID: 37002812
[TBL] [Abstract][Full Text] [Related]
11. [Different number of contraindications between summaries of product characteristics (SmPC) of drugs with the same active ingredients - an analysis of data from SmPCs of neuropsychiatric drugs].
Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
Fortschr Neurol Psychiatr; 2020 Mar; 88(3):152-169. PubMed ID: 31127605
[TBL] [Abstract][Full Text] [Related]
12. Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications-A Systematic Analysis of SmPCs/PI of Major Drug Markets.
Weisbach L; Schuster AK; Hartmann M; Fromm MF; Maas R; Farker K
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407541
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.
Salgado TM; Arguello B; Martinez-Martinez F; Benrimoj SI; Fernandez-Llimos F
Eur J Clin Pharmacol; 2013 Nov; 69(11):1973-9. PubMed ID: 23884582
[TBL] [Abstract][Full Text] [Related]
14. Discrepancies Between the Labels of Originator and Generic Pharmaceutical Products: Implications for Patient Safety.
Thoenes A; Cariolato L; Spierings J; Pinçon A
Drugs Real World Outcomes; 2020 Jun; 7(2):131-139. PubMed ID: 32323200
[TBL] [Abstract][Full Text] [Related]
15. The Quality and Reliability of Information in the Summaries of Product Characteristics.
Drelich E; Religioni U; Chung K; Kaźmierczak J; Blicharska E; Neumann-Podczaska A; Krysiński J; Merks P
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206371
[TBL] [Abstract][Full Text] [Related]
16. Consistency in the safety labeling of bioequivalent medications.
Duke J; Friedlin J; Li X
Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):294-301. PubMed ID: 23042584
[TBL] [Abstract][Full Text] [Related]
17. Results on patient-reported outcomes are underreported in summaries of product characteristics for new drugs.
Haag S; Junge L; Lotz F; McGauran N; Paulides M; Potthast R; Kaiser T
J Patient Rep Outcomes; 2021 Dec; 5(1):127. PubMed ID: 34874524
[TBL] [Abstract][Full Text] [Related]
18. [Antiepileptics in women of childbearing age and during pregnancy: comparison of specialized information with the current state of knowledge in Germany and Switzerland].
Winterfeld U; Gotta V; Rothuizen LE; Panchaud A; Rossetti AO; Buclin T
Nervenarzt; 2014 Jun; 85(6):738-46. PubMed ID: 24861194
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view.
Varnai R; Szabo I; Tarlos G; Szentpeteri LJ; Sik A; Balogh S; Sipeky C
Pharmacogenomics J; 2020 Jun; 20(3):380-387. PubMed ID: 31787752
[TBL] [Abstract][Full Text] [Related]
20. Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.
Reis-Pardal J; Rodrigues A; Rodrigues E; Fernandez-Llimos F
Pharmacogenomics J; 2017 Dec; 17(6):488-493. PubMed ID: 27241061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
